Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

2

Portfolio Exits

1

About Ryan Sarver

Ryan Sarver Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Ryan Sarver News

From Peach Term Sheet to Public Company: Our Journey with Hims & Hers

Jan 21, 2021

I was first introduced to Andrew Dudum , the CEO of Hims & Hers, in 2016 by Atomic’s Chester Ng . I was instantly impressed by Andrew’s energy, charisma and unbounded ambition. A year later Medha Agarwal , Ryan Sarver and I were sitting in Andrew’s office diving deeper into the vision for Hims & Hers and hearing about the initial success of the launch just weeks earlier. The three of us walked away extremely excited by Andrew’s passion for broadly redefining healthcare and knew we had to move fast. The very next day the entire Redpoint partnership cleared our calendars and went to the Atomic office in the Presidio to meet with the Hims & Hers team. At the end of the meeting, we asked for a few minutes to discuss the investment — all of us were truly inspired by what the team was building and knew we needed to be part of the Hims & Hers journey. After Andrew came back into the conference room we shared with him our enthusiasm for the team, the vision and the market opportunity. We surprised him with a manilla envelope inside of which was a signed, peach color (the Hims & Hers brand color) term sheet in the signature Hims & Hers font. The smile on his face suggested we hit upon a core emotion and connected with his appreciation of design. That was the start of our journey together. Hims & Hers was just an eight-person team at that point, treating hundreds of patients per day. Since then, the team has scaled to enabling over two million medical visits while continuing to innovate and expand the product portfolio. In just this past year alone, Hims & Hers has added everything from mental health services to primary care to access to one of the first, at-home saliva based tests for Covid authorized by the FDA under an emergency use authorization. Today is an exciting day as Hims & Hers becomes a public company. It still feels like the early days. We’re excited to continue on this journey and see the impact Hims & Hers will continue to have on redefining health and wellness as a public company. Stay tuned!

Ryan Sarver Investments

2 Investments

Ryan Sarver has made 2 investments. Their latest investment was in SmartThings as part of their Seed VC on December 12, 2012.

CBI Logo

Ryan Sarver Investments Activity

investments chart

Ryan Sarver Portfolio Exits

1 Portfolio Exit

Ryan Sarver has 1 portfolio exit. Their latest portfolio exit was SmartThings on August 15, 2014.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/15/2014

Acquired

$99M

1

Date

8/15/2014

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.